Wilderness Medical Society snowmass 2005 Page 135
6
90733
Meningococcal
V03.9
2+yr .5ml subq; b 3 5yr
90734 Meningococcal
Menactra V03.89 11-55 yrs 0.5 ml im
90669 Pneumococcal,
conjugate V03.82 2 59 mo; .5ml; 2,4,6m M
90732
Pneumococcal, polysaccharide V03.82 2+yr. 55+; .5ml sub or im R
90713
Polio, injectable
V04.0
.5 ml subq or im
M
86580 PPD
V74.1
.1
ml
intradermal
90675
Rabies, IM
V04.5
1 ml im 0,7, 21 or 28 d
-
90375
Rabies, Immune Globulin
V07.2
20 IU/kg around wound
-
90718
Tetanus-diphtheria Td
V06.5
7+ yr .5 ml im, 10yrs
M
90703
Tetanus toxoid
V03.7
Not for primary series
M
90389
Tetanus Immune Globulin
V07.2
For dirty wounds, unim.
-
90690
Typhoid, oral
V03.1
6+ yr 4 cap oral
-
90691
Typhoid vi
V03.1
2+yr .5ml im
-
90716
Varicella
V05.4
1-12 yr .5ml subq 13+ x2 R
90717
Yellow fever
V04.4
9 mo+ .5ml subq
-
VIS Vaccine Information Sheets (R ) required; (M) may use; (-) none availabl; (A)
available
CPT Administration Codes
CPT
Administration of Vaccine/Product
90471
90472
Any single or combination vaccine/toxoid
Any 2 or more single or combination vaccines/toxoids (Use for
each vaccine after the first)
90473
90474
Any single intranasal or oral vaccine
Any 2 or more intranasal or oral vaccines. (Use for each vaccine
after the first)
G0009 Pneumococcal
vaccine
G0010 Hepatitis
vaccine
G0008 Influenza
vaccine
90782 IG
(prophylactic)
In general CPT codes describe what you did in a clinical encounter and ICD-9 codes
describe why you did it. The ICD-9 codes will be listed in the diagnosis portion of the
claim. One of the counseling codes (99402 or 99403) may be used for the level of care
code if the patient has been referred and a report generated to the referring physician.
V65.8 may be used for diagnosis of preventative care or V01.9 for exposure to infectious
disease. Many third party and Medicare coverage for these codes is rejected.
Vaccine Information Sheets are available on the CDC website. The March 1988
Childhood Vaccine Injury Act requires that immunizations be recorded in the patient's
chart with the following information: administration date, vaccine name, vaccine
manufacturer, lot number, and the administrators name, business address, and title. It is
recommended that the site and route of administration and the expiration date of the
